Federal Efforts and Opportunities: Finding Our Footing in the Federal Policy and Funding Landscape

Given the shifting policy climate around PrEP since its 2012 FDA approval, key stakeholders may have uncertainty about the exact nature of the federal government’s response to PrEP. This session will provide an opportunity to sit down with members of the federal interagency PrEP subcommittee and other key federal partners to answer questions regarding the government’s plans for reaching the goals for PrEP access highlighted in the National HIV/AIDS Strategy. Presentations from representatives from key federal agencies and offices including HRSA, CDC, ONAP, SAMSHA, among others will open a group discussion on the key federal strategies, policies, and resources of which key stakeholders should be aware. The session will also be an important opportunity for government representatives to hear from community members and key stakeholders regarding the challenges they are experiencing in providing universal access to PrEP.


  • Richard Wolitski, PhD, Office of HIV/AIDS and Infectious Disease Policy, U.S. DHHS
  • Eugene McCray, MD, CDC National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
  • Cecilia Chung, Transgender Law Center
  • Guillermo Chacon, Latino Commission on AIDS
  • Antigone Dempsey, MEd, HRSA, HIV/AIDS Bureau